Ki-67 in breast cancer: Simulacra and simulation

被引:4
作者
Shet, Tanuja [1 ]
机构
[1] Tata Mem Hosp, Dept Histopathol, Annexe Bldg,Dr E Borges Rd, Mumbai, Maharashtra, India
关键词
KI67; METAANALYSIS; MARKER; STRATEGIES; EXPRESSION; THERAPY;
D O I
10.4103/ijc.IJC_565_19
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:231 / 233
页数:3
相关论文
共 21 条
[1]   Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials [J].
Albain, K. ;
Anderson, S. ;
Arriagada, R. ;
Barlow, W. ;
Bergh, J. ;
Bliss, J. ;
Buyse, M. ;
Cameron, D. ;
Carrasco, E. ;
Clarke, M. ;
Correa, C. ;
Coates, A. ;
Collins, R. ;
Costantino, J. ;
Cutter, D. ;
Cuzick, J. ;
Darby, S. ;
Davidson, N. ;
Davies, C. ;
Davies, K. ;
Delmestri, A. ;
Di Leo, A. ;
Dowsett, M. ;
Elphinstone, P. ;
Evans, V. ;
Ewertz, M. ;
Gelber, R. ;
Gettins, L. ;
Geyer, C. ;
Goldhirsch, A. ;
Godwin, J. ;
Gray, R. ;
Gregory, C. ;
Hayes, D. ;
Hill, C. ;
Ingle, J. ;
Jakesz, R. ;
James, S. ;
Kaufmann, M. ;
Kerr, A. ;
MacKinnon, E. ;
McGale, P. ;
McHugh, T. ;
Norton, L. ;
Ohashi, Y. ;
Paik, S. ;
Pan, H. C. ;
Perez, E. ;
Peto, R. ;
Piccart, M. .
LANCET, 2012, 379 (9814) :432-444
[2]   Ki67-no evidence for its use in node-positive breast cancer [J].
Andre, Fabrice ;
Arnedos, Monica ;
Goubar, Aicha ;
Ghouadni, Amal ;
Delaloge, Suzette .
NATURE REVIEWS CLINICAL ONCOLOGY, 2015, 12 (05) :296-301
[3]   Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer [J].
Cheang, Maggie C. U. ;
Chia, Stephen K. ;
Voduc, David ;
Gao, Dongxia ;
Leung, Samuel ;
Snider, Jacqueline ;
Watson, Mark ;
Davies, Sherri ;
Bernard, Philip S. ;
Parker, Joel S. ;
Perou, Charles M. ;
Ellis, Matthew J. ;
Nielsen, Torsten O. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (10) :736-750
[4]   Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients [J].
de Azambuja, E. ;
Cardoso, F. ;
de Castro, G., Jr. ;
Colozza, M. ;
Mano, M. S. ;
Durbecq, V. ;
Sotiriou, C. ;
Larsimont, D. ;
Piccart-Gebhart, M. J. ;
Paesmans, M. .
BRITISH JOURNAL OF CANCER, 2007, 96 (10) :1504-1513
[5]   Strategies for developing Ki67 as a useful biomarker in breast cancer [J].
Denkert, Carsten ;
Budczies, Jan ;
von Minckwitz, Gunter ;
Wienert, Stephan ;
Loibl, Sibylle ;
Klauschen, Frederick .
BREAST, 2015, 24 :S67-S72
[6]   Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group [J].
Dowsett, Mitch ;
Nielsen, Torsten O. ;
A'Hern, Roger ;
Bartlett, John ;
Coombes, R. Charles ;
Cuzick, Jack ;
Ellis, Matthew ;
Henry, N. Lynn ;
Hugh, Judith C. ;
Lively, Tracy ;
McShane, Lisa ;
Paik, Soon ;
Penault-Llorca, Frederique ;
Prudkin, Ljudmila ;
Regan, Meredith ;
Salter, Janine ;
Sotiriou, Christos ;
Smith, Ian E. ;
Viale, Giuseppe ;
Zujewski, Jo Anne ;
Hayes, Daniel F. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (22) :1656-1664
[7]   Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 [J].
Goldhirsch, A. ;
Wood, W. C. ;
Coates, A. S. ;
Gelber, R. D. ;
Thuerlimann, B. ;
Senn, H. -J. .
ANNALS OF ONCOLOGY, 2011, 22 (08) :1736-1747
[8]  
Hou YJ, 2017, AM J CLIN PATHOL, V148, P167, DOI [10.1093/AJCP/AQX059, 10.1093/ajcp/aqx059]
[9]   Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry [J].
Inwald, E. C. ;
Klinkhammer-Schalke, M. ;
Hofstaedter, F. ;
Zeman, F. ;
Koller, M. ;
Gerstenhauer, M. ;
Ortmann, O. .
BREAST CANCER RESEARCH AND TREATMENT, 2013, 139 (02) :539-552
[10]   The clinical significance of Ki-67 as a marker of prognostic value and chemosensitivity prediction in hormone-receptor-positive breast cancer: a meta-analysis of the published literature [J].
Liu, Yu ;
Yin, Wenjin ;
Yan, Tingting ;
Du, Yueyao ;
Shao, Zhimin ;
Lu, Jinsong .
CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (11) :1453-1461